These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8786170)

  • 1. Biocompatibility: is it a relevant consideration for today's haemodialysis?
    Shaldon S; Vienken J
    Int J Artif Organs; 1996 Apr; 19(4):201-14. PubMed ID: 8786170
    [No Abstract]   [Full Text] [Related]  

  • 2. Dilemma of membrane biocompatibility and reuse.
    Klinkmann H; Grassmann A; Vienken J
    Artif Organs; 1996 May; 20(5):426-32. PubMed ID: 8725623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of haemodialysis membranes.
    Hoenich NA; Levett D; Fawcett S; Woffindin C; Kerr DN
    J Biomed Eng; 1986 Jan; 8(1):3-8. PubMed ID: 3512914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of dialysis membranes: a comparative study.
    Martin-Malo A; Castillo D; Castro M; Pérez R; Rios A; Jaraba M; Aljama P
    Nephrol Dial Transplant; 1991; 6 Suppl 2():55-8. PubMed ID: 1866069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility criteria in hemodialysis.
    Cordonnier DJ; Forêt M
    Contrib Nephrol; 1989; 71():30-5. PubMed ID: 2680263
    [No Abstract]   [Full Text] [Related]  

  • 6. KHA-CARI guideline: dialysis adequacy (haemodialysis): dialysis membranes.
    Kerr PG; Toussaint ND; ;
    Nephrology (Carlton); 2013 Jul; 18(7):485-8. PubMed ID: 23672488
    [No Abstract]   [Full Text] [Related]  

  • 7. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of PMMA membranes in acute and chronic patients with renal failure.
    Manzoni C; Locatelli F
    Contrib Nephrol; 1999; 125():65-75. PubMed ID: 9895431
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes.
    Woffindin C; Hoenich NA
    Biomaterials; 1988 Jan; 9(1):53-7. PubMed ID: 3126842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of biocompatibility and its effect on haemodialysis treatment.
    Opatrný K
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v41-4. PubMed ID: 12817068
    [No Abstract]   [Full Text] [Related]  

  • 12. The relative effect of leukopenia and dialysate composition on the dialysis-associated hypoxemia.
    Hakim RM; Lowrie EG
    Proc Clin Dial Transplant Forum; 1980; 10():190-5. PubMed ID: 6810343
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitation of membrane biocompatibility.
    Colton CK
    Contrib Nephrol; 1987; 59():110-25. PubMed ID: 3502085
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane biocompatibility: clinical significance and therapeutic implications.
    Dumler F; Levin NW
    Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dialyzer reuse on leukopenia, hypoxemia and total hemolytic complement system.
    Hakim RM; Lowrie EG
    Trans Am Soc Artif Intern Organs; 1980; 26():159-64. PubMed ID: 7245475
    [No Abstract]   [Full Text] [Related]  

  • 17. Reuse and Biocompatibility of Hemodialysis Membranes: Clinically Relevant?
    Upadhyay A; Jaber BL
    Semin Dial; 2017 Mar; 30(2):121-124. PubMed ID: 28066932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodialysis leucopenia as an index of membrane biocompatibility.
    Aljama P; Garin JM; Torres A; Martin-Malo A; Moreno E; Perez-Calderon R
    Contrib Nephrol; 1984; 37():129-33. PubMed ID: 6713865
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of bio-incompatibility in haemodialysis.
    De Broe ME
    Contrib Nephrol; 1988; 62():35-43. PubMed ID: 3282796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.